ArriVent BioPharma, Inc. (AVBP) earnings
AVBP earnings moved a median of -0.83% by the close. Quarterly and annual AVBP reports and results, each read against the price at its own news timestamp. Back to the AVBP overview →
19 measured AVBP earnings events.
Where these AVBP earnings landedvs 19 measured AVBP earnings reactions
| Middle 50% of AVBP earnings reactions | -4.71% to +0.83% |
|---|---|
| Median reaction (to close) | -0.83% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 AVBP earnings events with a measured close landed between -4.71% and +0.83%; 26% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ArriVent BioPharma Reports Second Quarter 2026 Financial Results | Press release | +0.03% | -2.38% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.03% | -2.38% | |
| ArriVent BioPharma Reports First Quarter 2026 Financial Results | Press release | -3.77% | +2.04% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.77% | +2.04% | |
| Form 10-K ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.79% | -7.79% | |
| ArriVent BioPharma Reports Third Quarter 2025 Financial Results | Press release | -0.27% | -0.38% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.27% | -0.38% | |
| ArriVent BioPharma Reports Second Quarter 2025 Financial Results | Press release | -2.30% | -4.61% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.30% | -4.61% | |
| ArriVent BioPharma Reports First Quarter 2025 Financial Results | Press release | +4.14% | -0.79% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.67% | -4.81% | |
| Form 10-K ArriVent BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.17% | -6.45% | |
| ArriVent BioPharma Reports Third Quarter 2024 Financial Results | Press release | -0.32% | -11.34% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.32% | -11.34% | |
| ArriVent BioPharma Reports Second Quarter 2024 Financial Results | Press release | -0.25% | -0.83% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.25% | -0.83% | |
| ArriVent BioPharma Reports First Quarter 2024 Financial Results | Press release | +0.00% | +3.21% | |
| Form 10-Q ArriVent BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.21% | |
| Form 10-K ArriVent Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.45% | +2.18% |
Keep exploring
More AVBP: analyst actions → · SEC filings → · AVBP overview →